Literature DB >> 24389169

Pathogenic and therapeutic role of miRNAs in breast cancer.

Vittal Venkatasatya Kurisetty1, Rajkumar Lakshmanaswamy1, Chendil Damodaran1.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNA molecules present in all cell types, with sizes that vary from 18 to 28 nucleotides. miRNAs play significant roles in several biological processes, including development, differentiation, metabolism, initiation, and progression of cancer. In recent years, considerable research has been directed towards identifying miRNAs in peripheral blood from circulating tumor cells and disseminating tumor cells. Because these circulatory miRNAs are very stable and reproducible, their identification could be useful as prognostic markers as well as therapeutic agents for many cancers such as breast cancer. In this article, we review the role of specific circulatory miRNAs in breast cancer, with particular emphasis on their clinical importance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24389169     DOI: 10.2741/4192

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  5 in total

Review 1.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

2.  Prostate cancer cell proliferation is suppressed by microRNA-3160-5p via targeting of F-box and WD repeat domain containing 8.

Authors:  Ping Lin; Lijuan Zhu; Wenjing Sun; Zhengkai Yang; Hui Sun; Dong Li; Rongjun Cui; Xiulan Zheng; Xiaoguang Yu
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

3.  Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.

Authors:  A Valentino; A Calarco; A Di Salle; M Finicelli; S Crispi; R A Calogero; F Riccardo; A Sciarra; A Gentilucci; U Galderisi; S Margarucci; G Peluso
Journal:  Oncogene       Date:  2017-07-03       Impact factor: 9.867

4.  MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.

Authors:  Xiaoping Liu; Hailin Tang; Jianping Chen; Cailu Song; Lu Yang; Peng Liu; Neng Wang; Xinhua Xie; Xiaoti Lin; Xiaoming Xie
Journal:  Oncotarget       Date:  2015-08-21

Review 5.  Regulatory mechanisms of microRNAs in lung cancer stem cells.

Authors:  Tao Fan; Wei Wang; Boyou Zhang; Yao Xu; Lei Chen; Shize Pan; Hao Hu; Qing Geng
Journal:  Springerplus       Date:  2016-10-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.